Eagle PharmaceuticalsEGRX
13F holders, Q3 2024 (September 30)65holders −10
11new positions
21sold out
4famous investors
$3.73avg. 13F price*
At the end of Q3 2024, 65 institutions reported holding Eagle Pharmaceuticals Inc. (EGRX) in their 13F filings, down 10 from Q2 2024. 11 opened new positions and 21 sold out. The largest holders were Nantahala Capital Management, LLC ($8.8M), AIGH Capital Management LLC ($4.5M) and Citigroup Inc. ($3.7M). 4 famous investors held it, including Cliff Asness (0.0% of AQR Capital Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Eagle Pharmaceuticals Inc.
- CUSIP
- 269796108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $1.0M |
| Exits | 21 | $5.5M |
All 13F filers, Q2 2024 → Q3 2024: 809,716 shares bought and 2,088,704 shares sold, net −1,278,988 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 65 holders
| Nantahala Capital Management, LLC | 0.74% | Add +20.1% | 2,356,536 | $8.8M |
| AIGH Capital Management LLC | 2.12% | No change | 1,211,509 | $4.5M |
| Citigroup Inc. | 0.00% | Reduce -0.1% | 1,000,389 | $3.7M |
| Vanguard Group Inc. | 0.00% | Add +2.7% | 579,507 | $2.2M |
| AQR Capital Management | 0.00% | Reduce -46.2% | 374,992 | $1.4M |
| BlackRock, Inc. | 0.00% | — | 268,169 | $1.0M |
| Renaissance Technologies | 0.00% | Add +5.0% | 256,350 | $956K |
| Marshall Wace, LLP | 0.00% | Add +14.3% | 223,353 | $833K |
| Morgan Stanley | 0.00% | Reduce -36.0% | 192,213 | $717K |
| Two Sigma Advisers, LP | 0.00% | Reduce -17.7% | 185,058 | $690K |
| Assenagon Asset Management S.A. | 0.00% | Reduce -0.9% | 183,592 | $685K |
| J. Goldman & Co LP | 0.02% | Reduce -21.2% | 150,611 | $562K |
| RBF Capital, LLC | 0.03% | Add +11.7% | 143,078 | $534K |
| Jacobs Levy Equity Management, Inc. | 0.00% | New | 121,559 | $453K |
| Two Sigma Investments, LP | 0.00% | Reduce -10.9% | 119,312 | $445K |
| Tang Capital Management LLC | 0.03% | No change | 118,857 | $443K |
| Geode Capital Management, LLC | 0.00% | Reduce -2.0% | 105,846 | $395K |
| Invesco Ltd. | 0.00% | Add +0.4% | 82,775 | $309K |
| DGS Capital Management, LLC | 0.07% | Add +44.9% | 71,728 | $268K |
| Union Square Park Capital Management, LLC | 0.29% | New | 56,963 | $212K |
| AJOVista, LLC | 0.90% | Add +402.5% | 56,438 | $211K |
| D. E. Shaw & Co. | 0.00% | Reduce -68.1% | 54,625 | $204K |
| Bank of America Corp. | 0.00% | Reduce -84.3% | 51,006 | $190K |
| Deutsche Bank AG | 0.00% | No change | 48,800 | $182K |
| Trexquant Investment LP | 0.00% | Reduce -17.4% | 43,723 | $163K |
| Royal Bank of Canada | 0.00% | Reduce -1.8% | 36,925 | $138K |
| State Street Corp. | 0.00% | No change | 35,820 | $134K |
| Northern Trust Corp. | 0.00% | Reduce -66.0% | 31,955 | $119K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 31,900 | $119K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -60.2% | 31,495 | $117K |
| PDT Partners, LLC | 0.01% | No change | 30,011 | $112K |
| FMR LLC | 0.00% | Reduce -2.8% | 28,348 | $106K |
| Citadel Advisors | 0.00% | New | 26,013 | $97K |
| Jane Street Group, LLC | 0.00% | New | 25,837 | $96K |
| XTX Topco Ltd | 0.01% | Add +11.1% | 22,437 | $84K |
| BNP Paribas Financial Markets | 0.00% | Reduce -26.3% | 17,976 | $67K |
| Creative Planning | 0.00% | New | 15,686 | $59K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | Add +13.9% | 15,530 | $58K |
| Barclays PLC | 0.00% | Reduce -21.3% | 15,043 | $56K |
| Royce & Associates LP | 0.00% | No change | 13,821 | $52K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 13,300 | $50K |
| Blair William & Co. | 0.00% | Reduce -1.1% | 12,952 | $48K |
| Virtu Financial LLC | 0.00% | New | 12,890 | $48K |
| HSBC Holdings PLC | 0.00% | Reduce -13.3% | 11,396 | $45K |
| Stanley-Laman Group, Ltd. | 0.01% | No change | 12,000 | $45K |
| Jump Financial, LLC | 0.00% | Reduce -11.9% | 10,734 | $40K |
| Simplex Trading, LLC | 0.00% | New | 8,355 | $31K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Reduce -33.1% | 7,773 | $29K |
| Acadian Asset Management LLC | 0.00% | Reduce -72.9% | 7,155 | $26K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -76.2% | 6,152 | $23K |
| WealthCollab, LLC | 0.01% | Add +28.4% | 5,617 | $21K |
| Russell Investments Group, Ltd. | 0.00% | Reduce -63.7% | 3,561 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -15.5% | 2,702 | $10K |
| HighMark Wealth Management LLC | 0.00% | New | 2,200 | $8K |
| Headlands Technologies LLC | 0.00% | New | 1,674 | $6K |
| Group One Trading LLC | 0.00% | New | 785 | $3K |
| UBS Group AG | 0.00% | Reduce -0.4% | 480 | $2K |
| Archer Investment Corp | 0.00% | No change | 350 | $1K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 149 | $1K |
| Osaic Holdings, Inc. | 0.00% | Reduce -85.4% | 105 | $391 |
| Farther Finance Advisors, LLC | 0.00% | No change | 64 | $239 |
| Global Retirement Partners, LLC | 0.00% | No change | 49 | $183 |
| Front Row Advisors LLC | 0.00% | No change | 40 | $149 |
| Credit Agricole S A | 0.00% | New | 36 | $134 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 28 | $104 |
"% of holder's portfolio" is EGRX's weight in each manager's 13F, not the share of Eagle Pharmaceuticals Inc. the manager owns.